BioPharma

27 July, 2026 | Monday | Analysis

7 Countries Competing to Be the Region’s Next Biomanufacturing Hub

A siting decision for a biomanufacturing facility is one of the most expensive commitments a company makes, and it is made against a fifteen to twenty year horizon. The incentive package that dominates the pres...

Lab

17 July, 2026 | Friday | News

Metabolon Expands Microbiome Panel to Screen Over 800 Metabolites

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response Metabolon,...

BioTech

22 July, 2026 | Wednesday | Analysis

The Bioreactors Are Ours. The Consumables Are Not.

A new biologics plant is one of the easier things in medicine to photograph. The bioreactors are large and gleaming, the capacity figures are big and round, and between Hyderabad and Songdo there are more of bo...

Contract Services

24 July, 2026 | Friday | News

Samsung Bioepis Secures Exclusive Commercial Rights to Nectin-4 ADC Candidate SBE303

Ÿ   Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ   This agreement ...

Consumer Health

28 July, 2026 | Tuesday | News

Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis

The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...

Medtech

28 July, 2026 | Tuesday | News

Advita Introduces Activit-E Vitamin E Polyethylene to Equinoxe Reverse Shoulder System

Advita Ortho, a global medical technology leader,  announced the first clinical use of humeral liners manufactured with Activit-E® polyethylene, bringing its advanced vitamin E polyethylene technology ...

Cell & Gene

24 July, 2026 | Friday | News

Tikva Allocell Raises $8M Series A to Advance Off-the-Shelf CAR-T Therapy for Solid Tumours

Funding will support completion of IND-enabling activities and planned year-end IND submission for TAVST01, Tikva's lead off-the-shelf CAR-T candidate targeting B7-H3-positive solid tumors Tikva Allocell Pte. ...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close